Integra LifeSciences is sharing new clinical outcomes from nearly 1,000 procedures involving PriMatrix dermal scaffold. Data encompass analyses of 985 cases reported by 117 surgeons, covering treatment of surgical, traumatic and chronic ulcers as well as complex wounds featuring tunneling and undermining. A separate case series of 23 burn patients with significant comorbidities highlights PriMatrix's role in wound bed preparation for mixed thickness injuries.

Findings will be presented between April 8 and 17 at three major events: the Functional Diabetic Limb Salvage Conference in Washington D.C., the SAWC Spring | Wound Healing Society Conference in Charlotte and the American Burn Association Annual Meeting in Orlando. Poster sessions include performance in diabetic foot ulcers, clinician-reported utilization, complex wound outcomes and management of mixed thickness burn injuries with fetal bovine dermal scaffold.

Surgeons have reported incorporating PriMatrix into standard workflows for critical limb salvage and complex reconstructions, citing robust evidence across diverse wound types. Corporate leadership notes increasing clinical engagement and use volume, emphasizing the importance of real-world evidence in informing treatment strategies. The presentations are expected to bolster adoption of PriMatrix and reinforce Integra’s broader wound reconstruction portfolio.